A research opportunity is currently available in the Office of New Drugs/ Office of Nonprescription Drugs (ONPD), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) located in Silver Spring, Maryland.Many nonprescription products in the United States are marketed under the OTC monograph. Unlike FDA-approved products, individual OTC monograph products are not evaluated in clinical trials, and the formulation is not approved by FDA before marketing. These products may contain novel inactive ingredients that are not present in FDA-approved drug products, with unknown toxicities. The project will determine the percentage of OTC monograph pediatric cough and cold products (or drugs in another category) that contain ingredients not present in approved drug products, and start to identify those inactive ingredients that may pose a safety risk.The participant will gain an understanding of how nonprescription drug products are marketed in the United States. In addition, the participant will gain experience in leveraging information from internal databases to identify inactive ingredients unique to OTC monograph products, and learn how to assess the safety of inactive ingredients.QualificationsThe qualified candidate should have received a doctoral degree in one of the relevant fields. Degree must have been received within five years of the appointment start date.Previous knowledge in data mining is preferred.APPLY HERE: https://www.zintellect.com/Opportunity/Details/FDA-CDER-2021-0608The United States Government does not discriminate in employment on the basis of race, color, religion, sex (including pregnancy and gender identity), national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, membership in an employee organization, retaliation, parental status, military service, or other non-merit factor. Federal agencies must provide reasonable accommodation to applicants with disabilities where appropriate.